(Reuters) - Drugmaker Recro Pharma Inc said its lead painkiller was safe and well tolerated in post-operative orthopedic surgery patients in a mid-stage trial.
http://ift.tt/1mFIjFi
from Reuters: Health News
via animenewspro
Aucun commentaire:
Enregistrer un commentaire